floxuridine has been researched along with didimethylsulfoxide dichloroplatinum(ii) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Machover, D | 1 |
Anfossi, A; Anzá, M; Balletto, N; Cavaliere, P; Civalleri, D; Cosimelli, M; Di Tora, P; Durante, F; Mannella, E; Porcellana, M | 1 |
1 review(s) available for floxuridine and didimethylsulfoxide dichloroplatinum(ii)
Article | Year |
---|---|
Developments of the fluoropyrimidines as inhibitors of thymidylate synthetase: pharmacologic and clinical aspects.
Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Drug Synergism; Floxuridine; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Prodrugs; Pyrimidines; Thymidylate Synthase | 1991 |
1 trial(s) available for floxuridine and didimethylsulfoxide dichloroplatinum(ii)
Article | Year |
---|---|
Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens?
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Evaluation; Floxuridine; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Survival Rate | 1991 |